Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.89+0.18 (+10.53%)
Close on Nov 18, 2026Market cap $3.00MP/E –Yield –
Silo Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Silo Pharma's revenue for the twelve months ending Jun 30, 2026 was $54.08K, down 25.0% year over year. For fiscal 2025 it was $72.10K, up 0.0% from the year before. The highest annual figure on record is $72.10K in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.10K | 0.0% |
| FY2024 | Dec 31, 2024 | $72.10K | 0.0% |
| FY2023 | Dec 31, 2023 | $72.10K | 0.0% |
| FY2022 | Dec 31, 2022 | $72.10K | +76.2% |
| FY2020 | Dec 31, 2020 | $40.92K | +0.9% |
| FY2019 | Dec 31, 2019 | $40.57K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $18.03K | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | $18.03K | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | $18.03K | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | $18.03K | -0.0% |
| Q1 FY2025 | Mar 31, 2025 | $18.03K | -50.0% |
| Q4 FY2024 | Dec 31, 2024 | $18.03K | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $18.03K | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | $18.03K | +0.0% |
| Q1 FY2023 | Jun 30, 2023 | $36.05K | -47.1% |
| Q4 FY2022 | Dec 31, 2022 | $18.03K | -62.0% |
| Q3 FY2022 | Sep 30, 2022 | $18.03K | -18.5% |
| Q2 FY2022 | Jun 30, 2022 | $18.03K | +10.7% |
| Q2 FY2021 | Jun 30, 2021 | $68.09K | +2972.4% |
| Q1 FY2021 | Mar 31, 2021 | $47.43K | +16033.7% |
| Q4 FY2020 | Dec 31, 2020 | $22.13K | -45.1% |
| Q3 FY2020 | Sep 30, 2020 | $16.29K | +5976.5% |
| Q2 FY2020 | Jun 30, 2020 | $2.22K | – |
| Q1 FY2020 | Mar 31, 2020 | $294 | – |
| Q4 FY2019 | Dec 31, 2019 | $40.30K | – |
| Q3 FY2019 | Sep 30, 2019 | $268 | – |
See a number that looks wrong?